Gut microbiota and metabolite signatures predict severe immune-related adverse events in advanced hepatobiliary cancers.
Zhu C, Zhang D, Wang Y, Zhang C, Wang S, Xue J, Lan Z, Xun Z, Zhang L, Chao J, Liang Y, Xue W, Pu Z, Zhu T, Ning C, Sang X, Wang H, Jiang X, Yang X, Zhao H.
Zhu C, et al. Among authors: liang y.
J Adv Res. 2025 Aug 12:S2090-1232(25)00605-8. doi: 10.1016/j.jare.2025.08.016. Online ahead of print.
J Adv Res. 2025.
PMID: 40812586